Regulatory effect of caffeic acid phenethyl ester on type I collagen and interferon-gamma in bleomycin-induced pulmonary fibrosis in rat

Research in Pharmaceutical Sciences

Volumn 8, Issue 4, 2013, Pages 243-252

  Larki, A ^a   Hemmati, A A ^a   Arzi, A ^a   Ghafurian Borujerdnia, M ^a   Esmaeilzadeh, S ^b   Zad Karami, M R ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Bleomycin; CAPE; IFN ; Pulmonary fibrosis; Type I collagen

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; CAFFEIC ACID PHENETHYL ESTER; COLLAGEN; GAMMA INTERFERON; PROPOLIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL DENSITY; CONTROLLED STUDY; DISEASE SEVERITY; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG PARENCHYMA; LUNG WEIGHT; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 84873341436     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Biswas R, Bunderson-Schelvan M, Holian A. Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis. Pulm Med. 2011;2011:105707. Epub 2011/06/11.
2. Pardo A, Selman M, Kaminski N. Approaching the degradome in idiopathic pulmonary fibrosis. Int J Biochem Cell biol. 2008;40:1141-1155.
3. Gogali A, Wells AU. New pharmacological strategies for the treatment of pulmonary fibrosis. Ther Adv Respir Dis. 2010;4:353-366.
4. Desai B, Mattson J, Paintal H, Nathan M, Shen F, Beaumont M, et al. Differential expression of monocyte/macrophage- selective markers in human idiopathic pulmonary fibrosis. Exp Lung Res. 2011;37:227-238.
5. Wuyts WA, Willems S, Vos R, Vanaudenaerde BM, De Vleeschauwer SI, Rinaldi M, et al. Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model. Exp Lung Res. 2010;36:602-614.
6. Sharma R, Guleria R, Pande JN. Idiopathic pulmonary fibrosis: newer concepts and management strategies. Indian J Chest Dis Allied Sci. 2003;45:31-49.
7. Matsui R, Goldstein RH, Mihal K, Brody JS, Steele MP, Fine A. Type I collagen formation in rat type II alveolar cells immortalised by viral gene products. Thorax. 1994;49:201-206. (Pubitemid 24117444)
8. Emmez H, Kardes O, Dogulu F, Kurt G, Memis L, Baykaner MK. Role of antifibrotic cytokine interferon-gamma in the prevention of postlaminectomy peridural fibrosis in rats. Neurosurgery. 2008;62:1351-1357.
9. Hemmati AA, Nazari Z, Samei M. A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in rats. Pulm Pharmacol Ther. 2008;21:668-674.
10. Takemasa A, Ishii Y, Fukuda T. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice. Eur Respir J. 2012.
11. Gong LK, Li XH, Wang H, Zhang L, Chen FP, Cai Y, et al. Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats. Journal of ethnopharmacology. 2005;96:537-544. (Pubitemid 41556606)
12. Borrelli F, Maffia P, Pinto L, Ianaro A, Russo A, Capasso F, et al. Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia. 2002;73:S53-S63. (Pubitemid 35472204)
13. Park JH, Lee JK, Kim HS, Chung ST, Eom JH, Kim KA, et al. Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice. IntImmunopharmacol. 2004;4:429-436. (Pubitemid 38375975)
14. Russo A, Longo R, Vanella A. Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin. Fitoterapia. 2002;73:S21-S9. (Pubitemid 35472200)
15. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J, Kohn KW. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol. 1994;48:595-608. (Pubitemid 24257024)
16. Kurauchi Y, Hisatsune A, Isohama Y, Mishima S, Katsuki H. Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving heme oxygenase-1 and brain-derived neurotrophic factor. Br J Pharmacol. 2012;166:1151- 1168.
17. Fontanilla CV, Wei X, Zhao L, Johnstone B, Pascuzzi RM, Farlow MR, et al. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis. Neuroscience. 2011;205:185-193.
18. Schraufnagel DE, Mehta D, Harshbarger R, Treviranus K, Wang NS. Capillary remodeling in bleomycin-induced pulmonary fibrosis. AmJ Pathol. 1986;125:97.
19. Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur RespirJ. 1998;11:1218- 1221. (Pubitemid 28298579)
20. Rosenbloom J, Feldman G, Freundlich B, Jimenez SA. Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon. Biochem Biophys Res Commun. 1984;123:365-372. (Pubitemid 14030145)
21. Hyde DM, Henderson TS, Giri SN, Tyler NK, Stovall MY. Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp Lung Res. 1988;14:687-704.
22. Prior C, Haslam PL. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol. 1992;88:280-287.
23. Keane MP. The role of chemokines and cytokines in lung fibrosis. Eur Res Rev. 2008;17:151-156.
24. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270:27348-27357.
25. Gremy O, Benderitter M, Linard C. Caffeic acid phenethyl ester modifies the Th1/Th2 balance in ileal mucosa after gamma-irradiation in the rat by modulating the cytokine pattern. World J Gastroenterol : WJG. 2006;12:4996-5004. (Pubitemid 44323268)
26. Wang LC, Chu KH, Liang YC, Lin YL, Chiang BL. Caffeic acid phenethyl ester inhibits nuclear factorkappaB and protein kinase B signalling pathways and induces caspase-3 expression in primary human CD4+ T cells. Clin Exp Immunol. 2010;160:223- 232.
27. Sy LB, Yang LK, Chiu CJ, Wu WM. The immunoregulatory effects of caffeic acid phenethyl ester on the cytokine secretion of peripheral blood mononuclear cells from asthmatic children. Pediatr Neonatol. 2011;52:327-331.
28. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. AmJ Respir Crit Care Med. 2006;173:769-776.
29. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7-12.
30. Gurujeyalakshmi G, Wang Y, Giri SN. Taurine and niacin block lung injury and fibrosis by downregulating bleomycin-induced activation of transcription nuclear factor-κB in mice. J Pharmacol Exp Ther. 2000;293:82-90. (Pubitemid 30180926)
31. Márquez N, Sancho R, Macho A, Calzado MA, Fiebich BL, Muñoz E. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-κB transcription factors. J Pharmacol Exp Ther. 2004;308:993-1001. (Pubitemid 38263975)
32. Last JA, Reiser KM. Biosynthesis of collagen crosslinks. III. In vivo labeling and stability of lung collagen in rats with bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 1989;1:111-117.
33. Cutroneo KR, Sterling Jr KM. The biochemical and molecular basis of bleomycin-induced pulmonary fibrosis. Focus on Pulmonary Pharmacol Toxicol. 1988;1:1-22.
34. Moseley PL, Hemken C, Hunninghake GW. Augmentation of fibroblast proliferation by bleomycin. J Clini Invest. 1986;78:1150-1154. (Pubitemid 17181549)
35. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 1982;126:332-337. normal human lung. Am Rev Respir Dis. 1982;126:332-337. (Pubitemid 12047098)
36. Kelly J. Collagen. In: Massaro D, editor. Lung CellBbiol. New York: M. Dekker; 1989. p. 821-866.
37. Zhou XM, Zhao Y, He CC, Li JX. Preventive effects of Citrus reticulata essential oil on bleomycininduced pulmonary fibrosis in rats and the mechanism. Zhong xi yi jie he xue bao = J ChineseIintegr Med. 2012;10:200-209.
38. Thannickal VJ, Flaherty KR, Martinez FJ, Lynch JP 3rd. Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy. Expert Opin on pharmacother. 2004;5:1671-1686. (Pubitemid 39117710)
39. Zhang H, Liu X, Chen S, Wu J, Ye X, Xu L, et al. Tectorigenin inhibits the in vitro proliferation and enhances miR-338* expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis. J Ethnopharmacol. 2010;131:165-173.
40. Ozyurt H, Sogut S, Yildirim Z, Kart L, Iraz M, Armutcu F, et al. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta. 2004;339:65-75. (Pubitemid 37542459)
41. Hemmati AA, Zaeemzadeh N, Arzi A, Jalali T, Rashidi I. Protective Effect of Caffeic Acid Phenethyl Ester (CAPE) on Amiodarone-Induced Pulmonary Fibrosis in Rat. Iran J Pharm Res. 2011;10:321-328.
42. Gao J, Huang Y, Li P, Xu D, Li J, Liu Y, et al. Antifibrosis effects of total glucosides of Danggui- Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis. J Ethnopharmacol. 2011;136:21- 26.